Bigul

Board to consider Dividend

Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 30, 2011, inter alia, to consider and if thought fit to approve the Annual Accounts of the Company for the year ended on March 31, 2011 & also to consider and if thought fit to recommend dividend.
23-08-2011
Bigul

Financial Results for Jun 30, 2011

Gufic Biosciences Ltd has informed BSE about the Financial Results for the Period ended June 30, 2011.
12-08-2011
Bigul

Financial Results for Mar 31, 2011

Gufic Biosciences Ltd has informed BSE about the Financial Results for the period ended March 31, 2011.
12-05-2011
Bigul

Limited Review for the quarter ended Dec 31, 2010

Gufic Biosciences Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2010.
22-02-2011
Bigul

Financial Results for Dec 31, 2010

Gufic Biosciences Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.
14-02-2011
Bigul

Limited Review for the quarter ended Sep 30, 2010

Gufic Biosciences Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2010.
24-11-2010
Bigul

Financial Results for Sep 30, 2010

Gufic Biosciences Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2010.
15-11-2010
Bigul

Fixes Book Closure for Dividend & AGM

Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2010 to September 30, 2010 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on September 30, 2010.
01-09-2010
Bigul

Board recommends Dividend

Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 30, 2010, inter alia, has decided to declare dividend @ 5% i.e. Re. 0.05 per share subjected to shareholders approval at the Annual General Meeting.
30-08-2010
Next Page
Close

Let's Open Free Demat Account